| Bioactivity | β Amyloid(17-28) human is a β-amyloid peptide (Abeta), a lipid-induced amyloid core fragment. β Amyloid(17-28) human enhances aggregation of full-length β Amyloid40, producing toxic aggregates in Alzheimer's disease (AD)[1]. |
| Name | β Amyloid(17-28) human |
| Sequence | Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys |
| Shortening | LVFFAEDVGSNK |
| Formula | C61H92N14O19 |
| Molar Mass | 1325.47 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Liu R, et al. Residues 17-20 and 30-35 of beta-amyloid play critical roles in aggregation. J Neurosci Res. 2004 Jan 15;75(2):162-171. |
β Amyloid(17-28) human
CAS: F: C61H92N14O19 W: 1325.47
β Amyloid(17-28) human is a β-amyloid peptide (Abeta), a lipid-induced amyloid core fragment. β Amyloid(17-28) human
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.